This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations of James David Warren, Jr.
Introduction
James David Warren, Jr. is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of HCN channels. With a total of 2 patents to his name, Warren's work focuses on addressing HCN-related disorders.
Latest Patents
Warren's latest patents include "Substituted alkylphenols as HCN1 antagonists." These patents describe compounds that modulate HCN channels, which are crucial for the functioning of heart and brain cells. The patents also detail pharmaceutical compositions and kits that incorporate these compounds, along with methods for treating conditions related to HCN channels, such as pain.
Career Highlights
Warren is affiliated with Cornell University, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in treating various medical conditions.
Collaborations
Warren has collaborated with notable colleagues, including Gareth R. Tibbs and Peter A. Goldstein. Their combined expertise contributes to the advancement of research in their respective fields.
Conclusion
James David Warren, Jr. is a prominent inventor whose work in pharmaceutical innovation has the potential to impact the treatment of HCN-related disorders. His contributions to the field are significant and continue to evolve.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile